Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
Can J Cardiol. 2012 Jan-Feb;28(1):110-8. doi: 10.1016/j.cjca.2011.09.019. Epub 2011 Dec 10.
Quality indicators (QIs) are increasingly being used to measure and improve the quality of cardiac care. We conducted an international environmental scan to identify and critically appraise published QI development initiatives addressing cardiovascular disease (CVD). A review of the peer-reviewed and grey English-language literature was conducted to identify published CVD QI development initiatives. The quality of identified studies was assessed using a modified version of the Appraisal of Guidelines for Research and Evaluation (AGREE) II QI tool-an instrument originally developed for the assessment of the quality of clinical practice guidelines. An initial literature search identified 2314 potentially relevant abstracts of peer-reviewed articles. After a review of the abstracts, 120 full text articles were retrieved and reviewed. Of these, 20 articles and 1 peer-reviewed monograph were selected for critical appraisal (n = 21). Most of the initiatives were conducted in North America (76%) and were published after 2005 (62%). The majority (5 of 6) of the AGREE II QI domain scores were skewed toward higher values, including the median score for the 'overall quality' rating (83.3%). Of the CVD categories addressed within the 21 initiatives, heart failure was the most common (n = 10 QI indicator sets), followed by acute coronary syndromes (n = 8). Considerable variation was observed in the methods utilized and the degree of scientific rigour applied in the published international CVD QI development initiatives. Adoption of standardized methods could help improve the quality of QI development initiatives.
质量指标(QIs)越来越多地被用于衡量和改善心脏护理质量。我们进行了一项国际环境扫描,以确定和批判性评估已发表的针对心血管疾病(CVD)的 QI 开发计划。通过对同行评议和灰色英语文献的审查,确定了已发表的 CVD QI 开发计划。使用最初为评估临床实践指南质量而开发的评估指南研究和评估(AGREE)II QI 工具的修改版本评估了确定研究的质量。最初的文献搜索确定了 2314 篇可能相关的同行评审文章摘要。在审查摘要后,检索并审查了 120 篇全文文章。其中,20 篇文章和 1 篇同行评议专着被选中进行批判性评估(n = 21)。大多数计划(76%)在北美进行,并且是在 2005 年之后发布的(62%)。大多数(6 个中的 5 个)AGREE II QI 领域得分偏向于较高的值,包括“整体质量”评级的中位数得分(83.3%)。在 21 项计划中涵盖的 CVD 类别中,心力衰竭是最常见的(n = 10 QI 指标集),其次是急性冠状动脉综合征(n = 8)。在已发表的国际 CVD QI 开发计划中,所使用的方法和应用的科学严谨程度存在相当大的差异。采用标准化方法可以帮助提高 QI 开发计划的质量。